
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Stops Further Trials Of Lclusig On Leukemia Patients
Boston, MA 10/18/2013 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it would stop a study it had undertaken as a first option for leukemia. The













